The Effect of Botulinum Toxin and ESWT Applications on Spasticity and Functionality in Cerebral Palsy Patients

NAUnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 15, 2022

Primary Completion Date

July 15, 2023

Study Completion Date

July 15, 2023

Conditions
Cerebral Palsy, Spastic
Interventions
DEVICE

Extracorporeal Shock Wave Therapy

Spastic muscles will be determined by examination. Botulinum toxin-A will be injected into the spastic muscles with Stumplex. 1 week after the injection, patients will receive 3 sessions of radial ESWT treatment, 1 session/week. rESWT application will be applied with the 'MODUS ESWT' device and a 35 mm radial soft applicator will be used. rESWT will be applied with a soft applicator. The soft applicator is designed for application to sensitive and painful areas and applications will be painless.Shock waves will be applied at 1500/beat, 8 Hz, 0.030 Mj/mm2, 2 bar per muscle.

DRUG

Botilinum Toxin injection

Spastic muscles will be determined by examination. Botulinum toxin-A will be injected into the spastic muscles with Stumplex.

Trial Locations (1)

34899

RECRUITING

Marmara University School of Medicine Department of Physical Medicine and Rehabilitation, Istanbul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Marmara University

OTHER

NCT05627921 - The Effect of Botulinum Toxin and ESWT Applications on Spasticity and Functionality in Cerebral Palsy Patients | Biotech Hunter | Biotech Hunter